Brief: Acurx Pharmaceuticals Inc Files For Resale Of Up To 10.9 Million Shares Of Common Stock By The Selling Stockholder - SEC Filing
21/05/2025 21:40
Acurx Pharmaceuticals Inc ACXP.O: ACURX PHARMACEUTICALS INC FILES FOR RESALE OF UP TO 10.9 MILLION SHARES OF COMMON STOCK BY THE SELLING STOCKHOLDER - SEC FILING Source text: [ID:n0001104659-25-051615] Further company coverage: ACXP.O
Recent news on Acurx Pharmaceuticals
See all newsAcurx Pharmaceuticals Q1 net loss narrows as expenses fall
Brief: Acurx Pharmaceuticals To Discuss First Quarter 2026 Financial Results On May 12, 2026 Conference Call And Provide Business Update
Brief: Acurx Pharmaceuticals, Inc. Announces Closing Of Up To $7.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Acurx Pharmaceuticals Q4 net loss narrows on lower R&D spend
Acurx Pharma Q3 net loss narrows to $2 mln